title: The role of γδ T cells in pancreatic cancer: what could this mean for the clinic?
authors.affiliation: a S. Arthur Localio Laboratory, Department of Surgery , New York University School of Medicine , New York , NY , USA.
authors.forename: Donnele
authors.initials: D
authors.lastname: Daley
authors.affiliation: a S. Arthur Localio Laboratory, Department of Surgery , New York University School of Medicine , New York , NY , USA.|b S. Arthur Localio Laboratory, Department of Cell Biology , New York University School of Medicine , New York , NY , USA.
authors.forename: George
authors.initials: G
authors.lastname: Miller
mesh_terms: D021441:Carcinoma, Pancreatic Ductal / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D010190:Pancreatic Neoplasms / Q000276:immunology* / Q000628:therapy; D016176:T-Lymphocyte Subsets / Q000276:immunology*
keywords: IL-17; Pancreatic cancer; checkpoint ligands; immunotherapy; γδ T cells